Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
460-02-007 ISMRM Abstract

Ultrashort Echo Time Magnetization Transfer Imaging of Myelin in Alzheimer's Disease Using an APP Knock-In Mouse Model

Primary: Neuro - Alzheimer's Disease
Secondary: Acquisition & Reconstruction - Quantitative Imaging: head and neck
460-02-007 · From Bench to Bedside: All About the Brain in Health and Alzheimer’s Disease · Tuesday, 12 May, 9:15 AM–10:10 AM · Digital Posters Row A
Keywords: Alzheimer's Disease UTE-MT
Accepted
Jiaji Wang1,2, Jiyo S Athertya3, Xin Cheng4, Amanda Patel3, Qingbo Tang4, Eric Y Chang4, Shanshan Wang5, Yajun Ma3, Brian Head5, Guangyu Tang1, Jiang Du3,4,6
1Department of Radiology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China
2University of California, San Diego, United States of America
3Department of Radiology, University of California, San Diego, United States of America
4Radiology Service, VA San Diego Healthcare System, San Diego, United States of America
5Anesthesiology, VA San Diego Healthcare System, San Diego, United States of America
6Department of Bioengineering, University of California, Berkeley, United States of America
Presenting Author: Soo Hyun Shin

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Scheltens P, Strooper BD, Kivipelto M, Holstege H, Chételat G, Teunissen CE, et al. Alzheimer’s disease. The Lancet. 2021 Apr 24;397(10284):1577–90.
2. Long JM, Holtzman DM. Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell. 2019 Oct 3;179(2):312–39.
3. Mandal PK, Maroon JC, Garg A, Arora NK, Bansal R, Kaushik A, et al. Blood Biomarkers in Alzheimer’s Disease. ACS Chem Neurosci. 2023 Nov 15;14(22):3975–8.
4. Gouw AA, Seewann A, Vrenken H, van der Flier WM, Rozemuller JM, Barkhof F, et al. Heterogeneity of white matter hyperintensities in Alzheimer’s disease: post-mortem quantitative MRI and neuropathology. Brain. 2008 Dec 1;131(12):3286–98.
5. Scheltens Ph, Barkhof F, Leys D, Wolters ECh, Ravid R, Kamphorst W. Histopathologic correlates of white matter changes on MRI in Alzheimer’s disease and normal aging. Neurology. 1995 May;45(5):883–8.
6. Tian J, Raghavan S, Reid RI, Przybelski SA, Lesnick TG, Gebre RK, et al. White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer Disease. Neurology. 2023 May 30;100(22):e2269–78.
7. Falangola MF, Nie X, Ward R, McKinnon ET, Dhiman S, Nietert PJ, et al. Diffusion MRI detects early brain microstructure abnormalities in 2-month-old 3×Tg-AD mice. NMR Biomed. 2020 Sept;33(9):e4346.
8. Zerbi V, Kleinnijenhuis M, Fang X, Jansen D, Veltien A, Van Asten J, et al. Gray and white matter degeneration revealed by diffusion in an Alzheimer mouse model. Neurobiol Aging. 2013 May;34(5):1440–50.
9. Sun SW, Liang HF, Mei J, Xu D, Shi WX. In vivo diffusion tensor imaging of amyloid-β-induced white matter damage in mice. J Alzheimers Dis. 2014;38(1):93–101.
10. Falangola MF, Dhiman S, Voltin J, Jensen JH. Quantitative microglia morphological features correlate with diffusion MRI in 2-month-old 3xTg-AD mice. Magn Reson Imaging. 2023 Nov;103:8–17.
11. Kara F, Höfling C, Roßner S, Schliebs R, Van der Linden A, Groot HJM, et al. In Vivo Longitudinal Monitoring of Changes in the Corpus Callosum Integrity During Disease Progression in a Mouse Model of Alzheimer’s Disease. Curr Alzheimer Res. 2015;12(10):941–50.
12. Haris M, Yadav SK, Rizwan A, Singh A, Cai K, Kaura D, et al. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer’s disease. Neuroimage Clin. 2015;7:598–604.
13. Shu X, Qin YY, Zhang S, Jiang JJ, Zhang Y, Zhao LY, et al. Voxel-based diffusion tensor imaging of an APP/PS1 mouse model of Alzheimer’s disease. Mol Neurobiol. 2013 Aug;48(1):78–83.
14. Xiao D, Wang K, Theriault L, Charbel E, Alzheimer’s Disease Neuroimaging Initiative. White matter integrity and key structures affected in Alzheimer’s disease characterized by diffusion tensor imaging. Eur J Neurosci. 2022 Oct;56(8):5319–31.
15. Ranzenberger LR, Das JM, Snyder T. Diffusion Tensor Imaging. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Oct 25]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK537361/
16. Guglielmetti C, Boucneau T, Cao P, Van der Linden A, Larson PEZ, Chaumeil MM. Longitudinal evaluation of demyelinated lesions in a multiple sclerosis model using ultrashort echo time magnetization transfer (UTE-MT) imaging. Neuroimage. 2020 Mar;208:116415.

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/460-02-007